Amino Acid Profiles in the Biological Fluids and Tumor Tissue of CRC Patients

被引:5
作者
Santos, Marisa Domingues [1 ,2 ,3 ]
Barros, Ivo [2 ]
Brandao, Pedro [1 ,2 ,3 ]
Lacerda, Lucia [2 ,3 ,4 ]
机构
[1] Ctr Hosp Univ Santo Antonio, Hosp Santo Antonio, Colorectal Unit, P-4050651 Porto, Portugal
[2] Univ Porto, ICBAS Sch Med & Biomed Sci, UMIB Unit Multidisciplinary Res Biomed, P-4050313 Porto, Portugal
[3] ITR Lab Integrat & Translat Res Populat Hlth, P-4050313 Porto, Portugal
[4] Ctr Hosp Univ Santo Antonio, Ctr Genet Med Jacinto de Magalhaes, Genet Lab Serv, P-4050651 Porto, Portugal
关键词
colorectal cancer; biomarkers; amino acids; metabolomics; diagnosis; prognosis; treatment response; laboratorial findings; HUMAN COLORECTAL-CANCER; METABOLOMICS APPROACH; NEOADJUVANT CHEMOTHERAPY; BIOMARKERS; SIGNATURE; IDENTIFY; GLYCINE; PATHWAY; CELLS;
D O I
10.3390/cancers16010069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Amino acids are the fundamental building blocks of proteins and play a crucial role in various cellular functions, such as protein metabolism/catabolism pathways and redox signaling. They are also vital in normal and cancer metabolism. The concentrations of amino acids in blood, urine, and tissue samples of cancer patients differ from those of healthy individuals. These differences can be used for cancer screening, monitoring treatment response, and predicting tumor prognosis. Colorectal cancer (CRC) is one of the most common and deadly cancers. This review aims to gather reported amino acid abnormalities in blood, urine, and tissue samples of CRC patients and how these abnormalities can be used as potential tools in the multifold management of CRC, including screening, establishing cancer prognosis, and monitoring treatment response.Abstract Amino acids are the building blocks of proteins and essential players in pathways such as the citric acid and urea cycle, purine and pyrimidine biosynthesis, and redox cell signaling. Therefore, it is unsurprising that these molecules have a significant role in cancer metabolism and its metabolic plasticity. As one of the most prevalent malign diseases, colorectal cancer needs biomarkers for its early detection, prognostic, and prediction of response to therapy. However, the available biomarkers for this disease must be more powerful and present several drawbacks, such as high costs and complex laboratory procedures. Metabolomics has gathered substantial attention in the past two decades as a screening platform to study new metabolites, partly due to the development of techniques, such as mass spectrometry or liquid chromatography, which have become standard practice in diagnostic procedures for other diseases. Extensive metabolomic studies have been performed in colorectal cancer (CRC) patients in the past years, and several exciting results concerning amino acid metabolism have been found. This review aims to gather and present findings concerning alterations in the amino acid plasma pool of colorectal cancer patients.
引用
收藏
页数:15
相关论文
共 79 条
[41]   Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer [J].
Lou, Xiaoying ;
Zhou, Niyun ;
Feng, Lili ;
Li, Zhenhui ;
Fang, Yuqi ;
Fan, Xinjuan ;
Ling, Yihong ;
Liu, Hailing ;
Zou, Xuan ;
Wang, Jing ;
Huang, Junzhou ;
Yun, Jingping ;
Yao, Jianhua ;
Huang, Yan .
FRONTIERS IN ONCOLOGY, 2022, 12
[42]   An Integrated Proteomics and Metabolomics Approach for Defining Oncofetal Biomarkers in the Colorectal Cancer [J].
Ma, Yanlei ;
Zhang, Peng ;
Wang, Feng ;
Liu, Weijie ;
Yang, Jianjun ;
Qin, Huanlong .
ANNALS OF SURGERY, 2012, 255 (04) :720-730
[43]   Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection [J].
Miyagi, Yohei ;
Higashiyama, Masahiko ;
Gochi, Akira ;
Akaike, Makoto ;
Ishikawa, Takashi ;
Miura, Takeshi ;
Saruki, Nobuhiro ;
Bando, Etsuro ;
Kimura, Hideki ;
Imamura, Fumio ;
Moriyama, Masatoshi ;
Ikeda, Ichiro ;
Chiba, Akihiko ;
Oshita, Fumihiro ;
Imaizumi, Akira ;
Yamamoto, Hiroshi ;
Miyano, Hiroshi ;
Horimoto, Katsuhisa ;
Tochikubo, Osamu ;
Mitsushima, Toru ;
Yamakado, Minoru ;
Okamoto, Naoyuki .
PLOS ONE, 2011, 6 (09)
[44]   Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry [J].
Nishiumi, Shin ;
Kobayashi, Takashi ;
Kawana, Shuichi ;
Unno, Yumi ;
Sakai, Takero ;
Okamoto, Koji ;
Yamada, Yasuhide ;
Sudo, Kazuki ;
Yamaji, Taiki ;
Saito, Yutaka ;
Kanemitsu, Yukihide ;
Okita, Natsuko Tsuda ;
Saito, Hiroshi ;
Tsugane, Shoichiro ;
Azuma, Takeshi ;
Ojima, Noriyuki ;
Yoshida, Masaru .
ONCOTARGET, 2017, 8 (10) :17115-17126
[45]   A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer [J].
Nishiumi, Shin ;
Kobayashi, Takashi ;
Ikeda, Atsuki ;
Yoshie, Tomoo ;
Kibi, Megumi ;
Izumi, Yoshihiro ;
Okuno, Tatsuya ;
Hayashi, Nobuhide ;
Kawano, Seiji ;
Takenawa, Tadaomi ;
Azuma, Takeshi ;
Yoshida, Masaru .
PLOS ONE, 2012, 7 (07)
[46]  
Okada A, 1993, Tokushima J Exp Med, V40, P19
[47]  
Ong ES., 2010, Mol Cell Proteomics, DOI DOI 10.1074/MCP.M900551-MCP200
[48]   Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy [J].
Piotto, M. ;
Moussallieh, F. -M. ;
Dillmann, B. ;
Imperiale, A. ;
Neuville, A. ;
Brigand, C. ;
Bellocq, J. -P. ;
Elbayed, K. ;
Namer, I. J. .
METABOLOMICS, 2009, 5 (03) :292-301
[49]  
Piraud M, 2011, METHODS MOL BIOL, V708, P25, DOI 10.1007/978-1-61737-985-7_2
[50]   The changing faces of glutathione, a cellular protagonist [J].
Pompella, A ;
Visvikis, A ;
Paolicchi, A ;
De Tata, V ;
Casini, AF .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (08) :1499-1503